Authors:
Andreassen, OA
Ferrante, RJ
Klivenyi, P
Klein, AM
Dedeoglu, A
Albers, DS
Kowall, NW
Beal, MF
Citation: Oa. Andreassen et al., Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid, EXP NEUROL, 168(2), 2001, pp. 356-363
Citation: Tj. Montine et al., No difference in plasma or urinary F-2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls, ANN NEUROL, 48(6), 2000, pp. 950-950
Authors:
Volicer, L
Wells, JM
McKee, AC
Kowall, NW
Citation: L. Volicer et al., Enhanced inhibition of free radical-induced deoxyribose breakdown by Alzheimer brain homogenates, NEUROSCI L, 270(3), 1999, pp. 169-172
Authors:
Shefner, JM
Reaume, AG
Flood, DG
Scott, RW
Kowall, NW
Ferrante, RJ
Siwek, DF
Upton-Rice, M
Brown, RH
Citation: Jm. Shefner et al., Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy, NEUROLOGY, 53(6), 1999, pp. 1239-1246